206 related articles for article (PubMed ID: 11929788)
1. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells.
Barragán M; Bellosillo B; Campàs C; Colomer D; Pons G; Gil J
Blood; 2002 Apr; 99(8):2969-76. PubMed ID: 11929788
[TBL] [Abstract][Full Text] [Related]
2. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.
Ringshausen I; Schneller F; Bogner C; Hipp S; Duyster J; Peschel C; Decker T
Blood; 2002 Nov; 100(10):3741-8. PubMed ID: 12393602
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
[TBL] [Abstract][Full Text] [Related]
4. PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation.
Plate JM
Leuk Lymphoma; 2004 Aug; 45(8):1519-29. PubMed ID: 15370202
[TBL] [Abstract][Full Text] [Related]
5. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
6. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
[TBL] [Abstract][Full Text] [Related]
8. Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.
Barragán M; Campàs C; Bellosillo B; Gil J
Leuk Lymphoma; 2003 Nov; 44(11):1865-70. PubMed ID: 14738137
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells.
Bellosillo B; Dalmau M; Colomer D; Gil J
Blood; 1997 May; 89(9):3378-84. PubMed ID: 9129045
[TBL] [Abstract][Full Text] [Related]
10. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
11. Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1.
Herishanu Y; Gibellini F; Njuguna N; Hazan-Halevy I; Farooqui M; Bern S; Keyvanfar K; Lee E; Wilson W; Wiestner A
Leuk Lymphoma; 2011 Sep; 52(9):1758-69. PubMed ID: 21649540
[TBL] [Abstract][Full Text] [Related]
12. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.
Jones DT; Ganeshaguru K; Anderson RJ; Jackson TR; Bruckdorfer KR; Low SY; Palmqvist L; Prentice HG; Hoffbrand AV; Mehta AB; Wickremasinghe RG
Blood; 2003 Apr; 101(8):3174-80. PubMed ID: 12480711
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.
Shehata M; Schnabl S; Demirtas D; Hilgarth M; Hubmann R; Ponath E; Badrnya S; Lehner C; Hoelbl A; Duechler M; Gaiger A; Zielinski C; Schwarzmeier JD; Jaeger U
Blood; 2010 Oct; 116(14):2513-21. PubMed ID: 20576813
[TBL] [Abstract][Full Text] [Related]
14. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes.
Campàs C; Lopez JM; Santidrián AF; Barragán M; Bellosillo B; Colomer D; Gil J
Blood; 2003 May; 101(9):3674-80. PubMed ID: 12522004
[TBL] [Abstract][Full Text] [Related]
15. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
16. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
17. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.
Liu JF; Crépin M; Liu JM; Barritault D; Ledoux D
Biochem Biophys Res Commun; 2002 May; 293(4):1174-82. PubMed ID: 12054499
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet-induced junD activation and apoptosis in myeloblastic leukemia ML-1 cells.
Li T; Dai W; Lu L
J Biol Chem; 2002 Sep; 277(36):32668-76. PubMed ID: 12082101
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
20. Effect of TPA on fructose 2,6-bisphosphate levels and protein kinase C activity in B-chronic lymphocytic leukemia (B-CLL).
Colomer D; Vives Corrons JL; Bartrons R
Biochim Biophys Acta; 1991 Nov; 1097(4):270-4. PubMed ID: 1742331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
